By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Stryker Corporation

Stryker Corporation (0R2S.L)

LSE Currency in USD
$389.11
+$0.08
+0.02%
Last Update: 17 Jul 2025, 17:33
$148.70B
Market Cap
52.51
P/E Ratio (TTM)
0.86%
Forward Dividend Yield
$250.79 - $391.68
52 Week Range

0R2S.L Stock Price Chart

Explore Stryker Corporation interactive price chart. Choose custom timeframes to analyze 0R2S.L price movements and trends.

There is nothing to show.

0R2S.L Company Profile

Discover essential business fundamentals and corporate details for Stryker Corporation (0R2S.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Equipment & Services

IPO Date

6 Nov 2014

Employees

53.00K

CEO

Kevin A. Lobo

Description

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

0R2S.L Financial Timeline

Browse a chronological timeline of Stryker Corporation corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 29 Apr 2026

Upcoming earnings on 26 Jan 2026

Upcoming earnings on 27 Oct 2025

Upcoming earnings on 31 Jul 2025

Revenue estimate is $5.92B.

Dividend declared on 30 Jun 2025

A dividend of $0.84 per share was announced, adjusted to $0.84. The dividend will be paid on 31 Jul 2025.

Earnings released on 1 May 2025

EPS came in at $2.84 surpassing the estimated $2.71 by +4.80%, while revenue for the quarter reached $5.87B, missing expectations by -1.07%.

Dividend declared on 31 Mar 2025

A dividend of $0.84 per share was announced, adjusted to $0.84. The dividend was paid on 30 Apr 2025.

Earnings released on 28 Jan 2025

EPS came in at $4.01 surpassing the estimated $3.87 by +3.62%, while revenue for the quarter reached $6.44B, beating expectations by +1.18%.

Dividend declared on 31 Dec 2024

A dividend of $0.84 per share was announced, adjusted to $0.84. The dividend was paid on 31 Jan 2025.

Earnings released on 30 Oct 2024

EPS came in at $2.16 falling short of the estimated $2.77 by -22.02%, while revenue for the quarter reached $5.49B, beating expectations by +2.26%.

Dividend declared on 30 Sept 2024

A dividend of $0.80 per share was announced, adjusted to $0.80. The dividend was paid on 31 Oct 2024.

Earnings released on 31 Jul 2024

EPS came in at $2.14 falling short of the estimated $2.79 by -23.30%, while revenue for the quarter reached $5.42B, beating expectations by +0.32%.

Dividend declared on 28 Jun 2024

A dividend of $0.80 per share was announced, adjusted to $0.80. The dividend was paid on 31 Jul 2024.

Earnings released on 1 May 2024

EPS came in at $2.05 falling short of the estimated $2.36 by -13.14%, while revenue for the quarter reached $5.24B, beating expectations by +2.71%.

Dividend declared on 27 Mar 2024

A dividend of $0.80 per share was announced, adjusted to $0.80. The dividend was paid on 30 Apr 2024.

Earnings released on 29 Feb 2024

EPS came in at $2.98 falling short of the estimated $3.27 by -8.87%, while revenue for the quarter reached $5.82B, beating expectations by +3.80%.

Dividend declared on 28 Dec 2023

A dividend of $0.80 per share was announced, adjusted to $0.80. The dividend was paid on 31 Jan 2024.

Earnings released on 3 Nov 2023

EPS came in at $1.80 falling short of the estimated $2.43 by -25.93%, while revenue for the quarter reached $4.91B, beating expectations by +0.90%.

Dividend declared on 28 Sept 2023

A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 31 Oct 2023.

Earnings released on 4 Aug 2023

EPS came in at $1.92 falling short of the estimated $2.38 by -19.33%, while revenue for the quarter reached $5.00B, beating expectations by +3.52%.

Dividend declared on 29 Jun 2023

A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 31 Jul 2023.

Earnings released on 2 May 2023

EPS came in at $1.54 falling short of the estimated $2.00 by -23.00%, while revenue for the quarter reached $4.78B, beating expectations by +4.65%.

Dividend declared on 30 Mar 2023

A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 28 Apr 2023.

Earnings released on 1 Feb 2023

EPS came in at $1.47 falling short of the estimated $2.84 by -48.24%, while revenue for the quarter reached $5.20B, beating expectations by +4.79%.

Dividend declared on 29 Dec 2022

A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 31 Jan 2023.

Earnings released on 26 Oct 2022

EPS came in at $2.14 falling short of the estimated $2.20 by -2.73%, while revenue for the quarter reached $4.48B, beating expectations by +0.27%.

Dividend declared on 29 Sept 2022

A dividend of $0.70 per share was announced, adjusted to $0.70. The dividend was paid on 31 Oct 2022.

Earnings released on 25 Jul 2022

EPS came in at $1.72 falling short of the estimated $2.27 by -24.23%, while revenue for the quarter reached $4.49B, missing expectations by -0.78%.

Dividend declared on 29 Jun 2022

A dividend of $0.70 per share was announced, adjusted to $0.70. The dividend was paid on 29 Jul 2022.

Earnings released on 25 Apr 2022

EPS came in at $0.84 falling short of the estimated $1.95 by -56.72%, while revenue for the quarter reached $4.28B, beating expectations by +2.16%.

Dividend declared on 30 Mar 2022

A dividend of $0.70 per share was announced, adjusted to $0.70. The dividend was paid on 29 Apr 2022.

Earnings released on 27 Jan 2022

EPS came in at $1.73 falling short of the estimated $2.72 by -36.40%, while revenue for the quarter reached $4.70B, beating expectations by +1.10%.

Dividend declared on 30 Dec 2021

A dividend of $0.70 per share was announced, adjusted to $0.70. The dividend was paid on 31 Jan 2022.

Earnings released on 28 Oct 2021

EPS came in at $1.55, while revenue for the quarter reached $4.29B.

Earnings released on 30 Sept 2021

EPS came in at $1.14, while revenue for the quarter reached $4.16B.

Dividend declared on 29 Sept 2021

A dividend of $0.63 per share was announced, adjusted to $0.63. The dividend was paid on 29 Oct 2021.

Dividend declared on 29 Jun 2021

A dividend of $0.63 per share was announced, adjusted to $0.63. The dividend was paid on 30 Jul 2021.

Earnings released on 31 Mar 2021

EPS came in at $0.79, while revenue for the quarter reached $3.95B.

Dividend declared on 30 Mar 2021

A dividend of $0.63 per share was announced, adjusted to $0.63. The dividend was paid on 30 Apr 2021.

Earnings released on 31 Dec 2020

EPS came in at $1.49, while revenue for the quarter reached $4.26B.

Dividend declared on 30 Dec 2020

A dividend of $0.63 per share was announced, adjusted to $0.63. The dividend was paid on 29 Jan 2021.

Earnings released on 30 Sept 2020

EPS came in at $1.63, while revenue for the quarter reached $3.74B.

Dividend declared on 29 Sept 2020

A dividend of $0.58 per share was announced, adjusted to $0.58. The dividend was paid on 30 Oct 2020.

0R2S.L Stock Performance

Access detailed 0R2S.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
0R2S.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
0R2S.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More